New Delhi:The Drugs Controller General of India has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress...
#shorts#Watch the concluding part here: https://youtu.be/gOap8lLiYO8Please SUBSCRIBE to Yorubaplus Today by clicking on the Subscribe Button and don't forget to activate the Bell notification...
New Delhi: Will the 'Omicron' variant of Coronavirus be more dangerous than Delta? This question has raised many questions in the minds of scientists...